Existing cancer drug reduces blood vessel malformations in the brain
Researchers have identified a substance that reduces blood vessel lesions in the brain in the disease cerebral cavernous malformation (CCM). The substance is already used to treat brain tumors in children and could therefore be repurposed relatively rapidly to treat CCM, hopefully replacing surgery, currently the only treatment option.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Celebrity Traitors: Neuroscientist on whether you can really make someone yawn by faking it
United Kingdom
-
STI rates drop following antibiotic use recommendations for gay and bisexual men
United Kingdom
-
Study finds health care provider photos in waiting rooms can strengthen patient trust
United Kingdom
-
Pancreatic cancer study highlights body's natural molecules as potential treatment tools
United Kingdom
-
COVID inquiry: Four ways to improve support for people with intellectual disabilities
United Kingdom
-
TikTok Star Is Rallying Strangers to Make an 86-year-old’s Dream Come True (WATCH)
United Kingdom
-
Blood proteins could reveal clues to prostate cancer risk more than a decade before diagnosis
United Kingdom
-
Wearable pressure sensor uses cold-spray adhesion method for enhanced health monitoring
United Kingdom